Quantitative and qualitative liver proteome characteriztics of two inbred rat strains from integrative transcriptomics and proteomics

Autor: Teck Yew Low, Heesch, Sebastiaan Van, Toorn, Henk Van Den, Breukelen, Bas Van, Shabaz Mohammed, Cuppen, Edwin, Albert JR Heck, Guryev, Victor

presented in:Keystone Symposia: Omics Meets Cell Biology: Applications to Human Health and Disease in Taos, New Mexico, 2014 Quantitative and qualitative protein characteristics differ between individuals and are regulated at genomic, transcriptomic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a45380d3172396a802372b05359e196

Additional file 1: of Molecular dissection of germline chromothripsis in a developmental context using patient-derived iPS cells

Autor: Middelkamp, Sjors, Heesch, Sebastiaan Van, A. Braat, Ligt, Joep De, Iterson, Maarten Van, Simonis, Marieke, Roosmalen, Markus Van, Kelder, Martijn, Kruisselbrink, Evelien, Hochstenbach, Ron, Verbeek, Nienke, Ippel, Elly, Adolfs, Youri, R. Pasterkamp, Wigard Kloosterman, Ewart Kuijk, Cuppen, Edwin

Document containing all supplemental figures and legends. (PDF 30908Â kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f09c699060b0eae55ab3bc9e810695bc

The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy.

Autor: Martin MV; CureVac Netherlands B.V., Amsterdam, the Netherlands., Aguilar-Rosas S; CureVac Netherlands B.V., Amsterdam, the Netherlands., Franke K; CureVac Netherlands B.V., Amsterdam, the Netherlands., Pieterse M; CureVac Netherlands B.V., Amsterdam, the Netherlands., Langelaar JV; CureVac Netherlands B.V., Amsterdam, the Netherlands., Schreurs R; CureVac Netherlands B.V., Amsterdam, the Netherlands., Bijlsma MF; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands., Besselink MG; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.; Amsterdam UMC, location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands., Koster J; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Amsterdam, the Netherlands., Timens W; Department of Pathology and Medical Biology, University of Groningen, University, Medical Center Groningen, the Netherlands., Khasraw M; Duke University Medical Center, Duke University, Durham, North Carolina., Ashley DM; Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University, Durham, North Carolina., Keir ST; Duke University Medical Center, Duke University, Durham, North Carolina., Ottensmeier CH; Liverpool Head and Neck Centre, Institute of Systems, Molecular and Integrative Biology, University of Liverpool and Clatterbridge Cancer Center NHS Foundation Trust, Liverpool, UK., King EV; Department of Otorhinolaryngology, Head and Neck Surgery, Poole Hospital, Poole, UK., Verheij J; Amsterdam UMC, location University of Amsterdam, Department of Pathology, Amsterdam, the Netherlands., Waasdorp C; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Amsterdam, the Netherlands., Valk PJM; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., Engels SAG; The Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Oostenbach E; The Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Dinter JT; The Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Hofman DA; The Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Mok JY; Sanquin Reagents, Sanquin, Amsterdam, the Netherlands., van Esch WJE; Sanquin Reagents, Sanquin, Amsterdam, the Netherlands., Wilmink H; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.; Amsterdam UMC, location University of Amsterdam, Department of Medical Oncology, Amsterdam, the Netherlands., Monkhorst K; Netherlands Cancer Institute, Amsterdam, the Netherlands., Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Poel D; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the, Netherlands., Hiltermann TJN; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, the Netherlands., Kempen LCLTV; Department of Pathology and Medical Biology, University of Groningen, University, Medical Center Groningen, the Netherlands.; University of Antwerp, Antwerp University Hospital, Edegem, Belgium., Groen HJM; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, the Netherlands., Aerts JGJV; Erasmus Medical Center, Pulmonary Medicine, Rotterdam, the Netherlands., Heesch SV; The Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Löwenberg B; CureVac Netherlands B.V., Amsterdam, the Netherlands., Plasterk R; CureVac Netherlands B.V., Amsterdam, the Netherlands., Kloosterman WP; CureVac Netherlands B.V., Amsterdam, the Netherlands.

Publikováno v: Cancer immunology research [Cancer Immunol Res] 2024 Jun 04; Vol. 12 (6), pp. 759-778.